ViaCell, Inc. Reports Third Quarter 2007 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ViaCell, Inc. (Nasdaq: VIAC) today announced its consolidated financial results for the third quarter ended September 30, 2007. Sales of ViaCord®, ViaCell’s product for the preservation of umbilical cord blood, generated revenues of $18.0 million in the third quarter of 2007, representing a 24% increase over the $14.5 million of ViaCord revenues in the same period in 2006, reflecting increases in both processing and storage revenues. Gross margin from ViaCord sales for the third quarter of 2007 was 83% of product revenues compared to 80% in the third quarter of 2006.